blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4132942

EP4132942 - IN SITU METHODS FOR DETECTING TARGET NUCLEIC ACIDS BYHYBRIDIZATION AND A KIT THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  13.01.2023
Database last updated on 19.10.2024
FormerThe international publication has been made
Status updated on  16.10.2021
Most recent event   Tooltip15.10.2024The date on which the examining division becomes responsible, has been established 
15.10.2024Amendment by applicant 
Applicant(s)For all designated states
Advanced Cell Diagnostics, Inc.
7707 Gateway Blvd.
Newark, CA 94560 / US
[2023/07]
Inventor(s)01 / MATA, Miguel Angel
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
02 / SAHAJAN, Aparna
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
03 / MA, Xiao-Jun
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
04 / ZHANG, Bingqing
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
05 / WANG, Li
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
06 / WANG, Li-Chong
c/o ADVANCED CELL DIAGNOSTICS, INC. 7707 GATEWAY
BOULEVARD
NEWARK, California 94560 / US
 [2023/07]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Postfach 13 03 91
20103 Hamburg / DE
[2023/07]
Application number, filing date21784654.205.04.2021
[2023/07]
WO2021US25749
Priority number, dateUS202063006600P07.04.2020         Original published format: US 202063006600 P
[2023/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021207062
Date:14.10.2021
Language:EN
[2021/41]
Type: A1 Application with search report 
No.:EP4132942
Date:15.02.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 14.10.2021 takes the place of the publication of the European patent application.
[2023/07]
Search report(s)International search report - published on:US14.10.2021
(Supplementary) European search report - dispatched on:EP28.03.2024
ClassificationIPC:C07H21/00, C07H21/02, C07H21/04, C12N15/09, C12Q1/68, C12Q1/6841, C12Q1/6806
[2024/18]
CPC:
C12Q1/6806 (EP,US); C12Q1/6841 (EP,US); C12Q2600/178 (US)
C-Set:
C12Q1/6806, C12Q2523/10, C12Q2543/10, C12Q2565/518 (EP);
C12Q1/6841, C12Q2525/161, C12Q2565/40 (EP)
Former IPC [2023/07]C07H21/00, C07H21/02, C07H21/04, C12N15/09, C12Q1/68, C12Q1/6841
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/07]
TitleGerman:IN-SITU-VERFAHREN ZUR ERKENNUNG VON ZIELNUKLEINSÄUREN DURCH HYBRIDISIERUNG UND KIT DAFÜR[2023/07]
English:IN SITU METHODS FOR DETECTING TARGET NUCLEIC ACIDS BYHYBRIDIZATION AND A KIT THEREOF[2023/07]
French:IN SITU PROCÉDÉ DE DÉTECTION D'ACIDES NUCLÉIQUES CIBLES PAR HYBRIDATION, ET KIT ASSOCIÉ[2023/07]
Entry into regional phase28.09.2022National basic fee paid 
28.09.2022Search fee paid 
28.09.2022Designation fee(s) paid 
28.09.2022Examination fee paid 
Examination procedure28.09.2022Examination requested  [2023/07]
15.10.2024Amendment by applicant (claims and/or description)
15.10.2024Date on which the examining division has become responsible
Fees paidRenewal fee
27.04.2023Renewal fee patent year 03
29.04.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IY]WO9002173  (RESEARCH DEV CORP [US]);
 [IY]WO2011153354  (CELLAY INC [US], et al);
 [Y]WO2017066211  (ADVANCED CELL DIAGNOSTICS INC [US]);
 [IY]US2017336303  (CHAFIN DAVID [US], et al)
International search[A]WO9957309  (DAKO AS [DK], et al) [A] 1-11, 31-36, 45-51 * entire document *;
 [A]US2013130265  (PARIKH BHAIRAVI [US], et al) [A] 1-11, 31-36, 45-51 * entire document *;
 [X]US2013150264  (NIELSON KIRSTEN [DK], et al) [X] 45-51 * entire document *;
 [XY]US2013203055  (AURICH-COSTA JOAN [US]) [X] 1-5, 8-11, 31-36 * entire document * [Y] 6,7;
 [A]WO2016120195  (VENTANA MED SYST INC [US], et al) [A] 1-11, 31-36, 45-51* entire document *;
 [A]CN107312838  (UNIV GUANGXI) [A] 1-11, 31-36, 45-51 * entire document *;
 [Y]WO2019199643  (BIO TECHNE CORP [US]) [Y] 6, 7 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.